BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6247996)

  • 1. Mitogenic effect of 12-0 tetradecanoyl phorbol 13-acetate on non-human primate mononuclear cells and in vitro interaction with Epstein-Barr virus transformation.
    Sundar SK; Ablashi DV; Bengali ZH; Levine PH; Nonoyama M
    Arch Virol; 1980; 64(2):141-53. PubMed ID: 6247996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of enhancement of Epstein-Barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, TPA, with special reference to lowering of cytotoxicity of T cells.
    Harada S; Katsuki T; Yamamoto H; Hinuma Y
    Int J Cancer; 1981 May; 27(5):617-23. PubMed ID: 6270019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the mitogenic effects of a phorbol ester on lymphocytes from bovine spleen, lymph node and peripheral blood.
    Mastro AM; Pepin KG
    Comp Immunol Microbiol Infect Dis; 1983; 6(3):201-8. PubMed ID: 6627908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte activation by the tumor-promoting agent 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Abb J; Bayliss GJ; Deinhardt F
    J Immunol; 1979 May; 122(5):1639-42. PubMed ID: 221578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative response of normal and activated human lymphocytes to tetradecanoyl phorbol acetate.
    Ashman LK
    Cell Immunol; 1984 Sep; 87(2):613-25. PubMed ID: 6331899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Epstein-Barr virus by an new tumor promoter, teleocidin, compared to induction by TPA.
    Yamamoto H; Katsuki T; Hinuma Y; Hoshino H; Miwa M; Fujiki H; Sugimura T
    Int J Cancer; 1981 Aug; 28(2):125-9. PubMed ID: 6274809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of T lymphocytes by 12-O-tetradecanoylphorbol-13-acetate is resistant to inhibition by cyclosporin A.
    Kay JE; Meehan RT; Benzie CR
    Immunol Lett; 1983; 7(3):151-6. PubMed ID: 6607880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour promoter TPA enhances transformation of human leukocytes by Epstein-Barr virus.
    Yamamoto N; zur Hausen H
    Nature; 1979 Jul; 280(5719):244-5. PubMed ID: 221841
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of outgrowth of EB virus-transformed cells from normal human peripheral blood by a tumor promoter, TPA.
    Yamamoto H; Katsuki T; Harada S; Hinuma Y
    Int J Cancer; 1981 Feb; 27(2):161-6. PubMed ID: 6270011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 12-o-tetradecanoyl-phorbol-13-acetate (TPA) on the colony growth of human T lymphocytes.
    Foa R; Lusso P; Fierro MT; Giubellino MC; Ferrando ML; Pegoraro L
    Clin Exp Immunol; 1984 May; 56(2):377-82. PubMed ID: 6610514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic activity of 12-O-tetradecanoyl phorbol-13-acetate on peripheral blood lymphocytes from young and aged adults.
    Nagel JE; Chrest FJ; Adler WH
    Clin Exp Immunol; 1982 Jul; 49(1):217-24. PubMed ID: 7127899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cytotoxicity of tumour promoter TPA for EBV-negative human lymphoma cell lines and their EBV-converted sublines.
    Béchet JM; Guétard D
    Int J Cancer; 1983 Jul; 32(1):61-5. PubMed ID: 6305854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroids inhibit tumor promoting agent induced Epstein-Barr virus early antigens in Raji cells.
    Sundar SK; Ablashi DV; Armstrong GR; Zipkin M; Faggioni A; Levine PH
    Int J Cancer; 1981 Oct; 28(4):503-7. PubMed ID: 6273335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of Epstein-Barr virus. I. Characterization of viral DNA.
    Lin JC; Shaw JE; Smith MC; Pagano JS
    Virology; 1979 Nov; 99(1):183-7. PubMed ID: 227161
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of T cell activation with a non-mitogenic anti CD3 antibody and the phorbol ester TPA.
    Holter W; Majdic O; Stockinger H; Knapp W
    Clin Exp Immunol; 1985 Dec; 62(3):600-6. PubMed ID: 3002691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-induced early polypeptides in Raji and NC37 cells activated by diterpene ester TPA in combination with N-butyrate.
    Kawanishi M; Sugawara K; Ito Y
    Virology; 1981 Dec; 115(2):406-9. PubMed ID: 6274093
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of phorbol esters and cytokines (interleukin-2,-4, and -6) on the proliferation and surface phenotype of Epstein-Barr virus immortalised human B lymphocytes.
    Kosmas C; Epenetos AA; Courtenay-Luck NS
    Leuk Lymphoma; 1992 Sep; 8(1-2):109-15. PubMed ID: 1337296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumour promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) induces the production of lymphocyte-activating factors (LAP) in human lymphocyte cultures.
    Abb J; Deinhardt F
    Arch Geschwulstforsch; 1980; 50(4):327-31. PubMed ID: 6970023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive activity of 12-O-tetradecanoyl phorbol-13-acetate on the induction of cytotoxic T cells in vitro.
    Yamashita U
    Jpn J Cancer Res; 1985 Jul; 76(7):618-25. PubMed ID: 3928558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
    Edwards MC; Nouri AM; Gordon D; Evans FJ
    Mol Pharmacol; 1983 May; 23(3):703-8. PubMed ID: 6865912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.